Abhinay Sharma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Abhinay Sharma has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Emanuel Hanski
Department of Microbiology and Molecular Genetics, The Institute for Medical Research, Israel-Canada (IMRIC), Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel
3 shared publications Miriam Ravins
Department of Microbiology and Molecular Genetics, The Institute for Medical Research, Israel-Canada (IMRIC), Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, 9112102, Israel
2 shared publicationsAparna Anand
Department of Microbiology and Molecular Genetics, The Institute for Medical Research, Israel-Canada (IMRIC), Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, 9112102, Israel
1 shared publication- Aparna Anand
Department of Microbiology and Molecular Genetics, The Institute for Medical Research, Israel-Canada (IMRIC), Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel
1 shared publication Atul Kumar Johri
School of Life Sciences, Jawaharlal Nehru University, New Mehrauli Road, New Delhi 110067, India
1 shared publication- Atul Kumar Johri
School of Life Sciences, Jawaharlal Nehru University, New Delhi, India
1 shared publication
Latest Publications
- Open Access
- 14 April 2025
- Published by Springer Nature in EMBO Reports
- Vol. 26 (10) , 2767-2791
Group A Streptococcal asparagine metabolism regulates bacterial virulence
Group A Streptococcus (GAS) causes various human diseases linked to virulome expression predominantly regulated by the two-component system (TCS), CovR/S. Here, we demonstrate that asparagine (Asn) presence in a minimal chemically defined medium increases virulence gene expression in a CovR-dependent fashion. It also decreases the transcription of asparagine synthetase (AsnA), the ABC transporter responsible for Asn uptake (GlnPQ), and that of the hemolysin toxins responsible for scavenging Asn from the host. Metabolomics data show that Asn availability increases intracellular ADP/ATP ratio, which enhances phosphatase activity in structurally related CovS sensors and is probably responsible for the Asn-mediated decrease in CovR phosphorylation. Mutants deficient in AsnA, GlnPQ, asparaginase, (AsnB) activities are attenuated in a mouse model of human GAS invasive soft tissue infection. The similarity between the mechanisms of Asn-mediated regulation of GAS virulence and tumor growth suggests that, as in cancer, components maintaining Asn homeostasis could be targeted for anti-GAS treatments.
- 14 April 2025
- Published by Springer Nature in EMBO Reports
- Vol. 26 (10) , 2767-2791
Open AccessGroup A Streptococcal asparagine metabolism regulates bacterial virulence
Group A Streptococcus (GAS) causes various human diseases linked to virulome expression predominantly regulated by the two-component system (TCS), CovR/S. Here, we demonstrate that asparagine (Asn) presence in a minimal chemically defined medium increases virulence gene expression in a CovR-dependent fashion. It also decreases the transcription of asparagine synthetase (AsnA), the ABC transporter responsible for Asn uptake (GlnPQ), and that of the hemolysin toxins responsible for scavenging Asn from the host. Metabolomics data show that Asn availability increases intracellular ADP/ATP ratio, which enhances phosphatase activity in structurally related CovS sensors and is probably responsible for the Asn-mediated decrease in CovR phosphorylation. Mutants deficient in AsnA, GlnPQ, asparaginase, (AsnB) activities are attenuated in a mouse model of human GAS invasive soft tissue infection. The similarity between the mechanisms of Asn-mediated regulation of GAS virulence and tumor growth suggests that, as in cancer, components maintaining Asn homeostasis could be targeted for anti-GAS treatments.
- 4 August 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 13 (605)
Unfolded protein response inhibitors cure group A streptococcal necrotizing fasciitis by modulating host asparagine
Inhibiting the formation and release of host asparagine cures invasive group A streptococcal infections in mice.
- 4 August 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 13 (605)
Unfolded protein response inhibitors cure group A streptococcal necrotizing fasciitis by modulating host asparagine
Inhibiting the formation and release of host asparagine cures invasive group A streptococcal infections in mice.
- Open Access
- 15 July 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-11
Cross-serotype protection against group A Streptococcal infections induced by immunization with SPy_2191
Group A Streptococcus (GAS) infection causes a range of diseases, but vaccine development is hampered by the high number of serotypes. Here, using reverse vaccinology the authors identify SPy_2191 as a cross-protective vaccine candidate. From 18 initially identified surface proteins, only SPy_2191 is conserved, surface-exposed and inhibits both GAS adhesion and invasion. SPy_2191 immunization in mice generates bactericidal antibodies resulting in opsonophagocytic killing of prevalent and invasive GAS serotypes of different geographical regions, including M1 and M49 (India), M3.1 (Israel), M1 (UK) and M1 (USA). Resident splenocytes show higher interferon-γ and tumor necrosis factor-α secretion upon antigen re-stimulation, suggesting activation of cell-mediated immunity. SPy_2191 immunization significantly reduces streptococcal load in the organs and confers ~76-92% protection upon challenge with invasive GAS serotypes. Further, it significantly suppresses GAS pharyngeal colonization in mice mucosal infection model. Our findings suggest that SPy_2191 can act as a universal vaccine candidate against GAS infections.
- 15 July 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-11
Open AccessCross-serotype protection against group A Streptococcal infections induced by immunization with SPy_2191
Group A Streptococcus (GAS) infection causes a range of diseases, but vaccine development is hampered by the high number of serotypes. Here, using reverse vaccinology the authors identify SPy_2191 as a cross-protective vaccine candidate. From 18 initially identified surface proteins, only SPy_2191 is conserved, surface-exposed and inhibits both GAS adhesion and invasion. SPy_2191 immunization in mice generates bactericidal antibodies resulting in opsonophagocytic killing of prevalent and invasive GAS serotypes of different geographical regions, including M1 and M49 (India), M3.1 (Israel), M1 (UK) and M1 (USA). Resident splenocytes show higher interferon-γ and tumor necrosis factor-α secretion upon antigen re-stimulation, suggesting activation of cell-mediated immunity. SPy_2191 immunization significantly reduces streptococcal load in the organs and confers ~76-92% protection upon challenge with invasive GAS serotypes. Further, it significantly suppresses GAS pharyngeal colonization in mice mucosal infection model. Our findings suggest that SPy_2191 can act as a universal vaccine candidate against GAS infections.
- Open Access
- 24 January 2020
- Published by Oxford University Press (OUP) in Letters in Applied Microbiology
- Vol. 70 (4) , 252-258
AML1 protein interacts with influenza A virus neuraminidase and upregulates IFN‐β response in infected mammalian cells
Neuraminidase (NA) is an integral membrane protein of Influenza A virus (IAV) and primarily aids in the release of progeny virions, following the intracellular viral replication cycle. In an attempt to discover new functions of NA, we conducted a classical yeast two‐hybrid screen and found acute myeloid leukemia marker 1 (AML1) as a novel interacting partner of IAV‐NA. The interaction was further validated by co‐immunoprecipitation in IAV infected cells and in an in‐vitro coupled‐transcription translation system. Interestingly, we found an increase in the expression of AML1 upon IAV infection in a dose dependent manner. As expected, we also observed an increase in the IFNβ levels, the first line of defense against viral infections. Subsequently, when AML1 was downregulated using siRNA, the IFNβ levels were found to be remarkably reduced. Our study also shows that AML1 is induced upon IAV infection and results in the induction of IFNβ. Thus, AML1 is proposed to be an important player in IFN induction and has a role in an anti‐viral response against influenza A virus infection.
- 24 January 2020
- Published by Oxford University Press (OUP) in Letters in Applied Microbiology
- Vol. 70 (4) , 252-258
Open AccessAML1 protein interacts with influenza A virus neuraminidase and upregulates IFN‐β response in infected mammalian cells
Neuraminidase (NA) is an integral membrane protein of Influenza A virus (IAV) and primarily aids in the release of progeny virions, following the intracellular viral replication cycle. In an attempt to discover new functions of NA, we conducted a classical yeast two‐hybrid screen and found acute myeloid leukemia marker 1 (AML1) as a novel interacting partner of IAV‐NA. The interaction was further validated by co‐immunoprecipitation in IAV infected cells and in an in‐vitro coupled‐transcription translation system. Interestingly, we found an increase in the expression of AML1 upon IAV infection in a dose dependent manner. As expected, we also observed an increase in the IFNβ levels, the first line of defense against viral infections. Subsequently, when AML1 was downregulated using siRNA, the IFNβ levels were found to be remarkably reduced. Our study also shows that AML1 is induced upon IAV infection and results in the induction of IFNβ. Thus, AML1 is proposed to be an important player in IFN induction and has a role in an anti‐viral response against influenza A virus infection.